Norleual TFA, an angiotensin (Ang) IV analog, is a hepatocyte growth factor (HGF)/c-Met inhibitor with an IC 50 of 3 pM. Norleual TFA is an AT4 receptor antagonist and exhibits potent antiangiogenic activities.Appearance:SolidIn Vitro:/Norleual TFA at 20 and 50 pM significantly reduces HGF-dependent c-Met and Gab1 phosphorylation. 20 pM Norleual TFA dramatically reduces HGF-initiated association between Gab1 and c-Met in HEK293 cells. Norleual TFA markedly attenuates HGF-dependent c-MeIn Vivo:Norleual TFA (50 μg/kg; intraperitoneal injection; daily; for 2 weeks; C57BL/6 mice) suppresses pulmonary colonization by B16-F10 murine melanoma cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Biological Activity:Norleual TFA, an angiotensin (Ang) IV analog, is a hepatocyte growth factor (HGF)/c-Met inhibitor with an IC 50 of 3 pM. Norleual TFA is an AT4 receptor antagonist and exhibits potent antiangiogenic activities.
Specifications and Purity: ≥99%
Molecular Formula: C43H59F3N8O9
Molecular Weight: 888.97
- UPC:
- 51182010
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- N659268-1mg
- Product Size:
- 1mg
akash.verma@cenmed.com
(732) 447-1115





